Abiraterone - the newest treatment for prostate cancer
Scientists around the world have been fighting cancer for decades. This ailment can affect anyone. A special risk group is men, since they often do not pay attention to the first signs of the disease, delaying the course of the disease, which leads to its development and transition to severe stages.
One of the most common cancers in men is prostate cancer. A disease that affects the entire hormonal system of the body. However, early treatment can lead to complete recovery or long-term remission.
How did the new product appear?
More than 15 years ago, medical scientists developed an experimental treatment for prostate cancer using abiraterone acetate. Studies and observations of the effectiveness of the substance's effect on cancer cells were carried out until 2018. Today, abiraterone is widely used in treatment regimens for the detection of malignant prostate tumors.
Originally developed, abiraterone acetate was intended to suppress hormones in the body of a patient with prostate cancer. The modern formula suggests the transformation of abiraterone acetate into abiraterone, which acts as a hormone antagonist. In the process of taking a substance, it acts on the gland, suppressing the release of hormones. Thus, abiraterone acts as an androgen inhibitor, significantly affecting the biosynthesis of the prostate. In addition, abiraterone inhibits CYP17A1 by blocking testosterone and dihydrotestosterone production. According to clinical trials, abiraterone has a positive effect on the condition of patients even with an advanced stage of prostate cancer. So, observational data speak of cases of complete recovery and of patients whose lives were significantly extended thanks to abiraterone.
Where to buy Abiraterone?
Modern pharmacological companies offer various drugs containing abiraterone for the treatment of prostate cancer.
In the European part of the world, patients are most often prescribed Zytiga tablets, which were the first to be launched on the market. Despite the fact that prostate cancer affects more and more men every year, the manufacturer of the original drug is in no hurry to make it available - the price of Zytiga hovers around 170 thousand rubles per pack, which will be enough for one month of admission, while the course suggests treatment period up to 48 weeks. Due to the high cost of the drug, WHO transferred the license for the production of abiraterone to pharmaceutical companies from India, Egypt and Bangladesh. Due to this, drugs with abiraterone appeared on the market, which are significantly cheaper, and are not inferior in quality to the original. You can buy abiraterone in tablets in our pharmacy, we offer: • Zecyte (Cipla Ltd. India) ;
• Xbira (Cipla Ltd. India) ;
• Abirapro (Glenmark Pharmaceuticals Ltd. India) .
All drugs are certified and available for ordering in any city of Russia. For the purchase of medicines with abiraterone, contact the consultant on the website.